Leidos Holdings Health — Goodwill remained flat by 0.0% to $1.34B in Q1 2026 compared to the prior quarter. Over 2 years (FY 2021 to FY 2023), Health — Goodwill shows relatively stable performance with a 0.0% CAGR.
High levels suggest significant past acquisition activity, while sudden changes may indicate revaluation or potential future impairment risks.
The intangible asset value recorded when the Health segment acquires another business for a price exceeding the fair mar...
Commonly reported by companies with active M&A strategies in the government services space.
ldos_segment_health_goodwill| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $966.00M | $1.34B | $1.34B | $1.34B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +38.3% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +38.3% | +0.0% | — |